经超声穿透透声颅骨修补假体的经颅骨修补术超声检查:可行性、安全性和获益的综述
本综述系统检索Ovid Embase、Ovid Medline和Web of Science Core Collection,纳入16项研究(6项临床前研究、12项临床经验,共189例患者),评估经透声颅骨修补假体行经颅骨修补术超声检查的可行性、安全性与获益。临床使用的透声材料包括透明PMMA、不透光PMMA、聚醚醚酮和聚烯烃,并发症包括翻修或头皮愈合延迟(3%,6/189)等。作者建议未来研究收集定量测量数据以验证成像技术。
要点
- 经透声颅骨修补假体超声检查的临床数据新且异质,本综述为首个系统综述。
- 临床使用透声材料包括透明PMMA、不透光PMMA、聚醚醚酮和聚烯烃。
- 作者建议未来研究收集定量测量数据以验证成像技术。
核心结论
- 经透声颅骨修补假体超声检查的报道发现主要为定性,作者建议未来研究收集定量测量数据以验证成像技术。
研究设计与样本
- 系统文献综述,检索Ovid Embase、Ovid Medline和Web of Science Core Collection,纳入16项研究(6项临床前研究、12项临床经验),共189例患者。
主要发现
- 队列年龄从青少年到80多岁,女性占60%(113/189)。
- 适应证包括脑积水(20%,37/189)、肿瘤(15%,29/189)、后颅窝减压(14%,26/189)、创伤性脑损伤(11%,20/189)、搭桥(27%,52/189)、脑出血(4%,7/189)、缺血性卒中(3%,5/189)、动脉瘤和蛛网膜下腔出血(3%,5/189)、硬膜下血肿(2%,4/189)以及血管炎和其他骨修整(2%,4/189)。
- 并发症包括翻修或头皮愈合延迟(3%,6/189)、伤口感染(3%,5/189)、硬膜外血肿(2%,3/189)、脑脊液漏(1%,2/189)、新发癫痫(1%,2/189)和肿瘤复发并随后移除假体(<1%,1/189)。
- 大多数研究使用3-12 MHz的线阵或相控阵超声换能器,伪影来源包括假体曲率、气颅、接骨板和硬膜密封剂。
关键数值与推荐
- 临床使用的透声材料为透明PMMA(聚甲基丙烯酸甲酯)、不透光PMMA、聚醚醚酮和聚烯烃。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data on the effectiveness of transcranioplasty ultrasonography through sonolucent cranioplasty (SC) are new and heterogeneous. We performed the first systematic literature review on SC. Ovid Embase, Ovid Medline, and Web of Science Core Collection were systematically searched and published full text articles detailing new use of SC for the purpose of neuroimaging were critically appraised and extracted. Of 16 eligible studies, 6 reported preclinical research and 12 reported clinical experiences encompassing 189 total patients with SC. The cohort age ranged from teens to 80s and was 60% (113/189) female. Sonolucent materials in clinical use are clear PMMA (polymethylmethacrylate), opaque PMMA, polyetheretherketone, and polyolefin. Overall indications included hydrocephalus (20%, 37/189), tumor (15%, 29/189), posterior fossa decompression (14%, 26/189), traumatic brain injury (11%, 20/189), bypass (27%, 52/189), intracerebral hemorrhage (4%, 7/189), ischemic stroke (3%, 5/189), aneurysm and subarachnoid hemorrhage (3%, 5/189), subdural hematoma (2%, 4/189), and vasculitis and other bone revisions (2%, 4/189). Complications described in the entire cohort included revision or delayed scalp healing (3%, 6/189), wound infection (3%, 5/189), epidural hematoma (2%, 3/189), cerebrospinal fluid leaks (1%, 2/189), new seizure (1%, 2/189), and oncologic relapse with subsequent prosthesis removal (<1%, 1/189). Most studies utilized linear or phased array ultrasound transducers at 3-12 MHz. Sources of artifact on sonographic imaging included prosthesis curvature, pneumocephalus, plating system, and dural sealant. Reported findings were mainly qualitative. We, therefore, suggest that future studies should collect quantitative measurement data during transcranioplasty ultrasonography to validate imaging techniques.
引用
- Rossitto CP, Devarajan A, Zhang JY, et al. Transcranioplasty Ultrasonography Through a Sonolucent Prosthesis: A Review of Feasibility, Safety, and Benefits. World Neurosurg. 2023. PMID: 37422186. doi:10.1016/j.wneu.2023.06.136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。